Show
Sort by
-
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent
-
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
-
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: An experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy
-
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with 3 different contrast agents for therapy monitoring in a tumour bearing mouse model.
-
Is combined F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ?
-
Use of PET/CT in pancreatic lesions